Clinical Trial Update: Low Energy Therapy to Convert Ventricular Tachycardias [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated a low energy therapy to convert ventricular tachycardias; the study was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Drugs mentioned

• Low Energy Therapy

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Ventricular Tachycardia | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2017-07-17